Additionally, the heatmap shows a decrease in the expression of ACSL1, PARP9, TLR4, and ATG3 during anti-TB treatment, suggesting these genes as potential biomarkers for disease monitoring and therapeutic interventions. This evidence concerns the gene ACSL1 and tuberculosis.